Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 Sep;85(3):515–518. doi: 10.1111/j.1365-2249.1991.tb05759.x

Immunosuppression follows systemic T lymphocyte activation in the burn patient.

J A Teodorczyk-Injeyan 1, B G Sparkes 1, G B Mills 1, W J Peters 1
PMCID: PMC1535624  PMID: 1893634

Abstract

A general consensus that thermal injury affects T lymphocyte function adversely is supported particularly by the observation that burned patients' lymphocytes secrete reduced levels of biologically active IL-2 in vitro. In the same patients, however, high serum concentrations of the low-affinity IL-2 receptor (IL2R alpha), a product of an IL-2-activated gene, have been observed. In this study a significant proportion of patients also demonstrated over-physiological levels (from 2 to 500 U/ml) of serum IL-2 ascertained by immunoassay. Increases in serum IL-2 content correlated significantly (P less than 0.02) with those of serum IL-2R alpha during the first week post-burn. Later, serum IL-2R alpha levels continued to increase up to 30 days while IL-2 eventually declined. Thus, augmented secretion of IL-2R alpha appears related to the high serum IL-2 content. Therefore refractoriness to further immune stimulation may be due to early activation of the lymphoid system, rather than to an intrinsic incapacity of T lymphocytes for generating sequential responses.

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades E. W., Bosse D., Orr S., Gillespie T. Immune responses in humans while receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells: acute anergy to mitogens and recall antigens. Pathobiology. 1990;58(2):78–83. doi: 10.1159/000163566. [DOI] [PubMed] [Google Scholar]
  2. Antonacci A. C., Good R. A., Gupta S. T-cell subpopulations following thermal injury. Surg Gynecol Obstet. 1982 Jul;155(1):1–8. [PubMed] [Google Scholar]
  3. Calvano S. E., deRiesthal H. F., Marano M. A., Antonacci A. C. The decrease in peripheral blood CD4+ T cells following thermal injury in humans can be accounted for by a concomitant decrease in suppressor-inducer CD4+ T cells as assessed using anti-CD45R. Clin Immunol Immunopathol. 1988 May;47(2):164–173. doi: 10.1016/0090-1229(88)90069-4. [DOI] [PubMed] [Google Scholar]
  4. Deitch E. A., Berg R. Bacterial translocation from the gut: a mechanism of infection. J Burn Care Rehabil. 1987 Nov-Dec;8(6):475–482. [PubMed] [Google Scholar]
  5. Deitch E. A., Xu D., Sitting K., Wohlman M., Bridges R. M., Landry K., McDonald J. C. Ficoll-Hypaque leukocyte preparations from burned patients contain activated nonlymphoid cell populations that take up thymidine. J Trauma. 1989 Mar;29(3):277–283. doi: 10.1097/00005373-198903000-00001. [DOI] [PubMed] [Google Scholar]
  6. Depper J. M., Leonard W. J., Drogula C., Krönke M., Waldmann T. A., Greene W. C. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4230–4234. doi: 10.1073/pnas.82.12.4230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Donohue J. H., Rosenberg S. A. The fate of interleukin-2 after in vivo administration. J Immunol. 1983 May;130(5):2203–2208. [PubMed] [Google Scholar]
  8. Granelli-Piperno A. In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A. J Exp Med. 1988 Nov 1;168(5):1649–1658. doi: 10.1084/jem.168.5.1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kragel A. H., Travis W. D., Feinberg L., Pittaluga S., Striker L. M., Roberts W. C., Lotze M. T., Yang J. J., Rosenberg S. A. Pathologic findings associated with interleukin-2-based immunotherapy for cancer: a postmortem study of 19 patients. Hum Pathol. 1990 May;21(5):493–502. doi: 10.1016/0046-8177(90)90005-p. [DOI] [PubMed] [Google Scholar]
  10. Michie H. R., Eberlein T. J., Spriggs D. R., Manogue K. R., Cerami A., Wilmore D. W. Interleukin-2 initiates metabolic responses associated with critical illness in humans. Ann Surg. 1988 Oct;208(4):493–503. doi: 10.1097/00000658-198810000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Miller C. L., Baker C. C. Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest. 1979 Feb;63(2):202–210. doi: 10.1172/JCI109290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nau G. J., Moldwin R. L., Lancki D. W., Kim D. K., Fitch F. W. Inhibition of IL 2-driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody. J Immunol. 1987 Jul 1;139(1):114–122. [PubMed] [Google Scholar]
  13. Rosenstein M., Ettinghausen S. E., Rosenberg S. A. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol. 1986 Sep 1;137(5):1735–1742. [PubMed] [Google Scholar]
  14. Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985 Nov;135(5):3172–3177. [PubMed] [Google Scholar]
  15. Sparkes B. G. Influence of burn-induced lipid-protein complex on IL2 secretion by PBMC in vitro. Burns. 1991 Apr;17(2):128–135. doi: 10.1016/0305-4179(91)90136-5. [DOI] [PubMed] [Google Scholar]
  16. Teodorczyk-Injeyan J. A., Sparkes B. G., Falk R. E., Peters W. J., Mills G. B. Interleukin-2 secretion and transmembrane signalling in burned patients. J Trauma. 1988 Feb;28(2):152–157. doi: 10.1097/00005373-198802000-00004. [DOI] [PubMed] [Google Scholar]
  17. Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Falk R. E., Peters W. J. Impaired expression of interleukin-2 receptor (IL2R) in the immunosuppressed burned patient: reversal by exogenous IL2. J Trauma. 1987 Feb;27(2):180–187. doi: 10.1097/00005373-198702000-00015. [DOI] [PubMed] [Google Scholar]
  18. Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Falk R. E., Peters W. J. Increase of serum interleukin 2 receptor level in thermally injured patients. Clin Immunol Immunopathol. 1989 May;51(2):205–215. doi: 10.1016/0090-1229(89)90020-2. [DOI] [PubMed] [Google Scholar]
  19. Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Peters W. J., Falk R. E. Impairment of T cell activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression. Clin Exp Immunol. 1986 Sep;65(3):570–581. [PMC free article] [PubMed] [Google Scholar]
  20. Teodorczyk-Injeyan J. A., Sparkes B. G., Peters W. J. Serum interleukin-2 receptor as a possible mediator of immunosuppression after burn injury. J Burn Care Rehabil. 1989 Mar-Apr;10(2):112–118. doi: 10.1097/00004630-198903000-00003. [DOI] [PubMed] [Google Scholar]
  21. Wolfe J. H., Wu A. V., O'Connor N. E., Saporoschetz I., Mannick J. A. Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. Arch Surg. 1982 Oct;117(10):1266–1271. doi: 10.1001/archsurg.1982.01380340002002. [DOI] [PubMed] [Google Scholar]
  22. Wood J. J., Rodrick M. L., O'Mahony J. B., Palder S. B., Saporoschetz I., D'Eon P., Mannick J. A. Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg. 1984 Sep;200(3):311–320. doi: 10.1097/00000658-198409000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wood N. C., Symons J. A., Duff G. W. Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity? J Autoimmun. 1988 Aug;1(4):353–361. doi: 10.1016/0896-8411(88)90005-4. [DOI] [PubMed] [Google Scholar]
  24. Yasuda N., Lai P. K., Ip S. H., Kung P. C., Hinuma Y., Matsuoka M., Hattori T., Takatsuki K., Purtilo D. T. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood. 1988 Apr;71(4):1021–1026. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES